Literature DB >> 10852189

Morphometry of the head of the caudate nucleus in patients with velocardiofacial syndrome (del 22q11.2).

S Sugama1, P M Bingham, P P Wang, E M Moss, H Kobayashi, Y Eto.   

Abstract

UNLABELLED: Velocardiofacial syndrome (VCFS) is a chromosomal anomaly syndrome characterized by multiple congenital malformations, including cleft palate and cardiac anomalies. Many patients have attention-deficit (hyperactivity) disorders (AD[H]D) in childhood and schizophrenia in adulthood. We reviewed cranial magnetic resonance imaging (MRI) scans with particular attention to the head of the caudate nucleus and found that in control subjects, the head of the caudate was larger on the left than on the right, whereas VCFS patients showed a reversed right > left pattern or no significant asymmetry. A similar right > left asymmetry or a lack of this asymmetry has been reported in patients with AD(H)D.
CONCLUSIONS: These results suggest a common pathophysiological mechanism of behavioural and cognitive problems in patients with AD(H)D and those with VCFS.

Entities:  

Mesh:

Year:  2000        PMID: 10852189     DOI: 10.1080/080352500750027826

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  11 in total

Review 1.  A new account of the neurocognitive foundations of impairments in space, time and number processing in children with chromosome 22q11.2 deletion syndrome.

Authors:  Tony J Simon
Journal:  Dev Disabil Res Rev       Date:  2008

Review 2.  Bridging the gene-behavior divide through neuroimaging deletion syndromes: Velocardiofacial (22q11.2 Deletion) and Williams (7q11.23 Deletion) syndromes.

Authors:  Daniel Paul Eisenberg; Mbemba Jabbi; Karen Faith Berman
Journal:  Neuroimage       Date:  2010-03-03       Impact factor: 6.556

Review 3.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.

Authors:  Maria Karayiorgou; Tony J Simon; Joseph A Gogos
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

4.  Attentional functioning in individuals with 22q11 deletion syndrome: insight from ERPs.

Authors:  Daniela Mannarelli; Caterina Pauletti; Tommaso Accinni; Luca Carlone; Marianna Frascarelli; Guido Maria Lattanzi; Antonio Currà; Francesco Fattapposta
Journal:  J Neural Transm (Vienna)       Date:  2018-03-08       Impact factor: 3.575

Review 5.  Clues to the foundations of numerical cognitive impairments: evidence from genetic disorders.

Authors:  Tony J Simon
Journal:  Dev Neuropsychol       Date:  2011       Impact factor: 2.253

6.  Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Sarah Daniels; Jananne Khuri; Lisa Taylor; Maude Blundell; Kwame Anyane-Yeboa; Maria Karayiorgou
Journal:  Child Neuropsychol       Date:  2005-02       Impact factor: 2.500

7.  Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Thomas R Kwapil; Jessica Kaczorowski; Margaret N Berry; Cesar S Santos; Timothy D Howard; Dhruman Goradia; Konasale Prasad; Diwadkar Vaibhav; Rajaprabhakaran Rajarethinam; Edward Spence; Matcheri S Keshavan
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

8.  A cross-sectional analysis of the development of response inhibition in children with chromosome 22q11.2 deletion syndrome.

Authors:  Heather M Shapiro; Ling M Wong; Tony J Simon
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

9.  Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion.

Authors:  J Ellegood; S Markx; J P Lerch; P E Steadman; C Genç; F Provenzano; S A Kushner; R M Henkelman; M Karayiorgou; J A Gogos
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

10.  The development of cognitive control in children with chromosome 22q11.2 deletion syndrome.

Authors:  Heather M Shapiro; Flora Tassone; Nimrah S Choudhary; Tony J Simon
Journal:  Front Psychol       Date:  2014-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.